Date published: 2025-11-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

C3orf43 Inhibitors

The chemical class termed C3orf43 Inhibitors consists of a collection of compounds strategically selected to modulate signaling pathways associated with the C3orf43 protein. While direct inhibitors for C3orf43 may not be explicitly identified, potential activators and modulators of related pathways can be explored. Metformin, a widely used antidiabetic drug, activates AMP-activated protein kinase (AMPK), which can influence cellular energy homeostasis and potentially affect C3orf43 activity. Forskolin activates adenylate cyclase, leading to increased cAMP levels, a potential modulator of C3orf43 signaling pathways.

AICAR (Acadesine) activates AMPK, contributing to cellular energy homeostasis, providing another avenue for potential modulation of C3orf43. GW501516 (Cardarine) activates PPARδ, influencing metabolic pathways that might intersect with C3orf43 function. Dorsomorphin (Compound C) is an AMPK inhibitor, affecting AMPK-dependent cellular processes, potentially influencing C3orf43 regulation. LY294002 inhibits PI3-kinase, disrupting the PI3K/AKT signaling axis, which can potentially affect C3orf43 signaling. Rapamycin, an mTOR inhibitor, disrupts mTOR-dependent cellular events, providing another potential avenue for modulation. SB216763 is a GSK-3 inhibitor, impacting the Wnt/β-catenin signaling pathway, which could be linked to C3orf43. A-769662, another AMPK activator, can contribute to cellular energy homeostasis, potentially influencing C3orf43 activity. Rosiglitazone activates PPARγ, influencing transcriptional regulation that may intersect with C3orf43. PD98059 selectively inhibits MEK1, disrupting the MAPK pathway, which could be involved in C3orf43 signaling. SB431542 inhibits the TGF-β type I receptor, modulating the TGF-β pathway, providing another potential avenue for C3orf43 modulation. Collectively, these compounds offer a diverse toolkit for investigating the modulation of cellular processes associated with C3orf43, even in the absence of direct inhibitors, by targeting key pathways involved in its regulation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Metformin

657-24-9sc-507370
10 mg
$77.00
2
(0)

Activates AMP-activated protein kinase (AMPK)

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$60.00
$270.00
$350.00
48
(2)

Activates AMPK, influencing cellular energy homeostasis

GW501516

317318-70-0sc-202642
sc-202642A
1 mg
5 mg
$80.00
$175.00
28
(3)

Activates PPARδ, influencing metabolic pathways

Dorsomorphin dihydrochloride

1219168-18-9sc-361173
sc-361173A
10 mg
50 mg
$182.00
$736.00
28
(2)

AMPK inhibitor, affecting AMPK-dependent cellular processes

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3-kinase, disrupting the PI3K/AKT signaling

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor, disrupting mTOR-dependent cellular events

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
$70.00
$198.00
18
(1)

GSK-3 inhibitor, impacting Wnt/β-catenin signaling

A-769662

844499-71-4sc-203790
sc-203790A
sc-203790B
sc-203790C
sc-203790D
10 mg
50 mg
100 mg
500 mg
1 g
$180.00
$726.00
$1055.00
$3350.00
$5200.00
23
(2)

Activates AMPK, contributing to cellular energy homeostasis

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$118.00
$320.00
$622.00
$928.00
$1234.00
38
(1)

Activates PPARγ, impacting transcriptional regulation

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Selective inhibitor of MEK1, disrupting MAPK pathway